1. Home
  2. AKRO vs BKU Comparison

AKRO vs BKU Comparison

Compare AKRO & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • BKU
  • Stock Information
  • Founded
  • AKRO 2017
  • BKU 2009
  • Country
  • AKRO United States
  • BKU United States
  • Employees
  • AKRO N/A
  • BKU N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • BKU Savings Institutions
  • Sector
  • AKRO Health Care
  • BKU Finance
  • Exchange
  • AKRO Nasdaq
  • BKU Nasdaq
  • Market Cap
  • AKRO 2.4B
  • BKU 2.7B
  • IPO Year
  • AKRO 2019
  • BKU 2011
  • Fundamental
  • Price
  • AKRO $28.09
  • BKU $40.72
  • Analyst Decision
  • AKRO Strong Buy
  • BKU Hold
  • Analyst Count
  • AKRO 7
  • BKU 10
  • Target Price
  • AKRO $43.20
  • BKU $36.20
  • AVG Volume (30 Days)
  • AKRO 617.2K
  • BKU 923.6K
  • Earning Date
  • AKRO 11-08-2024
  • BKU 10-22-2024
  • Dividend Yield
  • AKRO N/A
  • BKU 2.85%
  • EPS Growth
  • AKRO N/A
  • BKU N/A
  • EPS
  • AKRO N/A
  • BKU 2.44
  • Revenue
  • AKRO N/A
  • BKU $919,935,000.00
  • Revenue This Year
  • AKRO N/A
  • BKU N/A
  • Revenue Next Year
  • AKRO N/A
  • BKU $6.83
  • P/E Ratio
  • AKRO N/A
  • BKU $16.66
  • Revenue Growth
  • AKRO N/A
  • BKU 3.57
  • 52 Week Low
  • AKRO $14.41
  • BKU $24.34
  • 52 Week High
  • AKRO $37.00
  • BKU $41.65
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 38.58
  • BKU 64.62
  • Support Level
  • AKRO $31.12
  • BKU $39.99
  • Resistance Level
  • AKRO $35.11
  • BKU $41.65
  • Average True Range (ATR)
  • AKRO 1.99
  • BKU 1.14
  • MACD
  • AKRO -0.53
  • BKU 0.49
  • Stochastic Oscillator
  • AKRO 11.68
  • BKU 87.52

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located primarily throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

Share on Social Networks: